| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.42B | 25.74B | 25.45B | 22.71B | 23.33B | 22.36B |
| Gross Profit | 7.34B | 6.95B | 7.50B | 6.88B | 8.09B | 8.29B |
| EBITDA | 9.59B | 8.76B | 9.47B | 8.59B | 9.29B | 10.26B |
| Net Income | 2.73B | 2.20B | 1.88B | 1.84B | 3.46B | 4.30B |
Balance Sheet | ||||||
| Total Assets | 58.84B | 58.17B | 54.85B | 52.51B | 51.09B | 48.02B |
| Cash, Cash Equivalents and Short-Term Investments | 4.02B | 4.05B | 3.92B | 5.97B | 8.15B | 8.07B |
| Total Debt | 10.40B | 11.50B | 9.74B | 10.20B | 10.95B | 9.77B |
| Total Liabilities | 27.33B | 27.40B | 26.07B | 25.20B | 26.22B | 25.00B |
| Stockholders Equity | 19.50B | 18.90B | 17.58B | 16.69B | 15.55B | 13.98B |
Cash Flow | ||||||
| Free Cash Flow | 6.25B | 1.12B | 2.35B | 455.00M | 1.67B | 5.60B |
| Operating Cash Flow | 6.05B | 5.61B | 7.16B | 5.28B | 5.14B | 7.71B |
| Investing Cash Flow | -4.28B | -4.47B | -5.03B | -4.96B | -3.25B | -1.78B |
| Financing Cash Flow | -2.56B | -1.88B | -3.28B | -2.65B | -1.81B | -1.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $123.92B | 9.00 | 15.67% | 0.95% | 25.14% | 73.19% | |
71 Outperform | $87.05B | 24.09 | 14.52% | 1.25% | 5.41% | ― | |
70 Outperform | $147.14B | 27.74 | 42.25% | 2.07% | 17.38% | 26.70% | |
69 Neutral | $170.72B | 13.01 | 16.59% | 4.60% | 7.59% | -13.66% | |
68 Neutral | $73.06B | 22.50 | 6.34% | 10.04% | 0.64% | -62.00% | |
65 Neutral | $43.83B | 11.03 | 5.87% | 1.03% | -1.31% | 149.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |